Canopy Growth shares jumped Monday afternoon following news that the Ontario-based cannabis company has been granted a licence by New York state to process and produce hemp, a member of the cannabis plant family.
The Smiths Falls-based company’s shares closed up 11.17 per cent at $56.45 on the Toronto Stock Exchange. The stock closed Friday at $50.78, up 29 per cent from $39.28 at the close on Jan. 2 – the first day of trading in 2019.
The company announced plans to invest between US$100 million and US$150 million at its proposed New York hemp operations, although the exact location hasn’t been decided.
These planning principles reflect the hospital’s ambitious vision of the future of health care in our city.
Kanata North’s biggest mix n’ mingle event is almost here: in a few more than six weeks, it’s the Discover Technata Career Fair.
The U.S. federal government designated hemp as an agricultural product late last year, making it a potential source of legal cannabidiol, or CBD, a non-psychoactive compound also found in marijuana.
Cannabis products with higher levels of tetrahydrocannabinol, or THC, remain listed as restricted drugs by the U.S. federal government.
Canopy says it will source hemp exclusively from U.S. farmers for its U.S. operations once up and running.
Canopy Growth says it’s in the process of evaluating a number of sites that will become one of its first extraction and processing facilities outside Canada and it plans to announce the specific location within 100 days.
The company – which received a $5-billion investment in August from alcoholic beverage maker Constellation Brands – said it was evaluating sites in the Southern Tier region of New York state near Pennsylvania.
U.S. Senator Charles (Chuck) Schumer, leader of the minority Democrats, said in Canopy’s statement that he expects a “major shot in the arm” for the Southern Tier economy and for farmers.